We are live on ! Find out more
CC

Capital Counsel Portfolio holdings

AUM $2.35B
1-Year Est. Return 21.34%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
+21.34%
3 Year Est. Return
+69.88%
5 Year Est. Return
+102.01%
10 Year Est. Return
+473.12%
AUM
$1.8B
AUM Growth
-$17.9M
Cap. Flow
+$10.4M
Cap. Flow %
0.58%
Top 10 Hldgs %
90.84%
Holding
54
New
2
Increased
15
Reduced
8
Closed
2

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$8.93M
2
ANET icon
Arista Networks
ANET
+$2.33M
3
CME icon
CME Group
CME
+$1.18M
4
MTD icon
Mettler-Toledo International
MTD
+$599K
5
HD icon
Home Depot
HD
+$423K

Sector Composition

Rank Sector Weight
1 Technology 30.24%
2 Healthcare 22.71%
3 Financials 19.37%
4 Consumer Staples 11.26%
5 Communication Services 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRGV icon
51
Energy Vault
NRGV
$517M
$208K 0.01%
81,725
VUZI icon
52
Vuzix
VUZI
$194M
$72.6K ﹤0.01%
20,000
RDI icon
53
Reading International Class A
RDI
$33.2M
-113,350
Closed -$300K
RETA
54
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-17,000
Closed -$1.73M

Similar funds

Capital Counsel's Q3 2023 Portfolio in Review

As of Q3 2023, Capital Counsel held 54 positions worth $1.8B, down 0.99% from $1.81B the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Capital Counsel's Q3 2023 filing shows 2 new, 15 increased, 8 reduced and 2 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 834 shares worth $328K. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $1.73M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Capital Counsel's largest Q3 2023 buy was Vanguard S&P 500 ETF: 834 shares worth $328K.
  • Capital Counsel added most to Qualcomm in Q3 2023, an estimated $8.93M increase.
  • Capital Counsel's biggest Q3 2023 reduction was Alphabet (Google) Class C, cutting an estimated $1.44M.
  • Capital Counsel fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $1.73M.
  • Capital Counsel's ten largest holdings make up 91% of its $1.8B portfolio in Q3 2023.
  • Capital Counsel opened 2 new positions and closed 2 in Q3 2023.
  • Capital Counsel's portfolio value fell 0.99% quarter-over-quarter to $1.8B.

Based on Capital Counsel's 13F filing for Q3 2023, filed 14 Nov 2023.